Select your cookie preferences

We use essential cookies and similar tools that are necessary to provide our site and services. We use performance cookies to collect anonymous statistics, so we can understand how customers use our site and make improvements. Essential cookies cannot be deactivated, but you can choose “Customize” or “Decline” to decline performance cookies.

If you agree, AWS and approved third parties will also use cookies to provide useful site features, remember your preferences, and display relevant content, including relevant advertising. To accept or decline all non-essential cookies, choose “Accept” or “Decline.” To make more detailed choices, choose “Customize.”

Sign in
Your Saved List Become a Channel Partner Sell in AWS Marketplace Amazon Web Services Home Help

Patients' Mindset: Antidiabetics - DPP-4 Inhibitors and Combinations

Provided By: Medisafe Inc.

Patients' Mindset: Antidiabetics - DPP-4 Inhibitors and Combinations

Provided By: Medisafe Inc.

Gain actionable insights from self-identified reasons for non-adherence to a missed dose by patients self-report taking a combination of antidiabetic DPP-4 Inhibitors and/or additional medications . Assess and trend patient mindsets from the self-reported and de-identified Medisafe users indicating reasons for skipping specific doses from a complex medication regimen.

Product offers

The following offers are available for this product. Choose an offer to view the pricing and access duration options for the offer. Select an offer and continue to subscribe. Your subscription begins on the date that your request is approved by the provider. Additional taxes or fees might apply.

Public offer

Payment schedule: Upfront payment | Offer auto-renewal: Supported
$36,000 for 12 months

Overview

Medisafe has a comprehensive database of de-identified medication adherence activity and behaviors. This product represents one subset of this data. To learn more about our insights- - contact us at dataaws@medisafe.com)

This product provides a snapshot of US Medisafe users who report taking DPP-4 class drug in combination with additional (including supplements and over-the-counter) medications who also responded to a survey of reasons for skipping any dose of a scheduled medication. This self-reported de-identified data includes gender and age characteristics as well as responses to the Medisafe generated survey identifying the mindset of skipped dose behaviors . Gain actionable insights by tracking trends, commonalities and outliers from a targeted population of patients self-reporting and tracking their medications.

Highlights

  • Drug Class: DPP-4 Inhibitors and Combinations
  • Learn self-identified reasons for skipping medication doses
  • View (de-identified) user segments by age and gender breakdown, adherence level, time on medication and self-reported reasons for skipping doses
  • Initial file includes dataset from most recently ended quarter
  • Subsequent dataset file for most recently ended quarter/month until end of subscription
  • Geographic coverage: USA

General Description: Medisafe is the leader of digital therapeutic companions for medication management. Currently there are over six million users world-wide who have incorporated our holistic approach to medication management into their everyday lives. Medisafe has generated over 12 billion data points of de-identified data representing medication behaviors spanning diverse therapeutic areas. Medisafe’s data products are sourced from real-world behaviors while maintaining the highest degree of patient privacy and security protection. Our de-identified data sets combine age and gender demographics, self reported medication management and digital behavior patterns and is both HIPAA and GDPR compliant.

The data products offered on AWS are exclusively for qualified research endeavors. If interested in purchasing any of our data products we invite you to submit your request here dataaws@medisafe.com and we will reach out to discuss terms and prices.

Updated: December 5, 2019

Product subscription includes: initial snapshot file from most recent completed quarter of the year, and subsequent quarterly (or monthly) snapshots for duration of annual subscription. Product subscription renewed annually.

Provided By
Fulfillment Method
AWS Data Exchange

Data sets (1)

You will receive access to the following data sets

Revision access rules
All historical revisions | All future revisions
Name
Type
Data dictionary
AWS Region
Non-adherence reasons : DPP-4 Inhibitors and Combinations
Not included
US East (N. Virginia)

Usage information

By subscribing to this product, you agree that your use of this product is subject to the provider's offer terms including pricing information and Data Subscription Agreement . Your use of AWS services remains subject to the AWS Customer Agreement  or other agreement with AWS governing your use of such services.

Support information

Support contact email address
Support contact URL
-
Refund policy
No refunds. Can’t find a solution for your use case? Contact us at dataaws@medisafe.com.
General AWS Data Exchange support